SLeep Evaluation and Effectiveness Protocol for Intensive Care Units (SLEEP-ICU)
Phase 3
- Conditions
- Sleep deprivationDeliriumNeurological - Other neurological disorders
- Registration Number
- ACTRN12624000991516
- Lead Sponsor
- South Metropolitan Health Service
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
1.Adult patient aged 18 years or older admitted to the ICU
2.Expected to remain in the ICU overnight from the time of enrollment.
3.Capacity to complete a self-reported sleep assessment*
4.Subjectively reported sleep disturbance during the current ICU admission**
* Absence of altered mental state and ability to understand sleep questions and provide responses
** According to patient-reported survey (Richards-Campbell Sleep Questionnaire)
Exclusion Criteria
1.Contraindication to dexmedetomidine (including but not limited to allergy and bradycardia)
2.Currently receiving dexmedetomidine
3.Treating clinician believes study participation is not in the patient’s best interest
4.Pregnancy or breastfeeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method